Astex President Awarded Prous Institute-Overton and Meyer Award for New Technologies in Drug Discovery

Astex President Awarded Prous Institute-Overton and Meyer Award for New Technologies in Drug Discovery

DACOGEN(R) Receives a Positive Regulatory Recommendation in the European Union for Treatment of Acute Myeloid Leukemia

DACOGEN® Receives a Positive Regulatory Recommendation in the European Union for Treatment of Acute Myeloid Leukemia

Astex Pharmaceuticals Earns $5.4 Million Milestone on Phase I Trial Initiation of a FGFR Kinase Inhibitor

Astex Pharmaceuticals Earns $5.4 Million Milestone on Phase I Trial Initiation of a FGFR Kinase Inhibitor